Navigation Links
Disease-Focused Businesses Prepare For Impact Of Healthcare Reform As 2014 Nears
Date:11/5/2013

BURLINGTON, Mass., Nov. 5, 2013 /PRNewswire/ -- Decision Resources Group, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that market access is drastically changing for companies focused on a wide range of specific indications, including schizophrenia, diabetes and prostate cancer.  The different facets of healthcare reform -- from Medicaid expansion to health insurance exchanges and Accountable Care Organizations (ACOs) -- are driving payers and physicians to behave in different ways.

Decision Resources Group's upcoming webinar, entitled "Healthcare Reform's Effect: Analysis of Brand-Level Impact for 2014 Market Access Strategy" discusses the key developments in Healthcare Reform that will shape the way disease-focused companies will do business tomorrow. Specific brand-level examples will include: how exchange-based plans will affect usage of schizophrenia and depression therapies such as Abilify and Cymbalta, how ACOs will impact prescribing of brands such as Singulair, Dulera or Advair by pulmonologists, and how physician prescribing of Januvia and Onglyza will change as use of electronic health records and e-prescribing expands. This webinar will take place December 13, 2013 at 1p Eastern and is open to media and Pharmaceutical executives. Register for the webinar here.

"Dramatic change is underway in market access. Healthcare reform is driving payer responses that are actively restructuring how drugs will be reimbursed and prescribed -- and our research is revealing how stakeholders can jump in and literally shape healthcare history," said Roy Moore, Senior Director at Decision Resources, a Decision Resources Group company. "For instance, the movement to ACOs includes direct monetary incentives to motivate doctors towards giving more weight to hospitalization metrics in their prescribing decisions, requiring a new strategy for communicating a specific therapy's advantages over other drugs. Pharma executives who understand how the ACA's implications affect their brands will be able to incorporate forward-thinking insight into 2014 market access strategy."

About Physician & Payer Forum Reports -- 2013 "Physician & Payer Dynamics" SeriesU.S. Physician & Payer Forum is the industry's only syndicated primary market research product that includes insights from both physicians and HMO/PPO pharmacy directors to get a true sense of how both parties shape a market. The 2013 "Physician & Payer Dynamics" Series investigates how novel payer-led care coordination and financing programs impact prescribing behavior.  The Series helps pharmaceutical brand managers and marketers develop effective market access strategies within the new paradigms brought about by Healthcare Reform. Find out more here.

2013 "Physician & Payer Dynamics" Report Titles:

  • NEW Healthcare Reform: Impact of Expanding Role for Medicaid and Health Exchanges on Prescribing of Schizophrenia, Bipolar Disorder and Unipolar Depression Drugs
  • NEW Payer Strategies and Access: Narrow Networks, Employed Physicians and Provider Consolidation's Impact on Prescribing Decisions for Cardiologists – Acute Coronary Syndrome and Post-Hospital Atrial Fibrillation
  • NEW Impact of Payer-Imposed Strategies on Market Access in NSCLC and Prostate Cancer: Clinical Pathways, Bundled Payments and Accountable Care Organization Contracting
  • NEW Market Access for High-Cost Brands in Multiple Sclerosis, Oncology, and Rheumatoid Arthritis
  • NEW Accountable Care Organizations: How Will Payer and Provider Adoption of this Model Impact Prescribing Trends in Asthma and COPD?
  • E-Prescribing and Electronic Health Records: Impact of Technology on Prescribing for Hypertension and Diabetes
  • About Decision Resources Group
    Decision Resources Group is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources Group at www.DecisionResourcesGroup.com.

    All company, brand or product names contained in this document may be trademarks or registered trademarks of their respective holders.For more information, contact:Lydia Smith

    Elizabeth MarshallDecision Resources Group

    Decision Resources Group 781-993-2594

    781-993-2563 lsmith@dresources.com

    emarshall@dresources.com


    '/>"/>
    SOURCE Decision Resources Group
    Copyright©2012 PR Newswire.
    All rights reserved

    Related medicine technology :

    1. PCMA: New Report Shows Drugstore Lobby Agenda Raises Rx Costs for Small Businesses, Government Programs
    2. PCMA: New Report Shows Anti-PBM Laws Could Raise Health Care Costs for Oklahoma Businesses, Consumers, Government Programs
    3. Proprietary Medical Device Data Helps Businesses Adapt in the Shifting Healthcare Landscape, Post-Affordable Care Act
    4. Wacoms New DTU-1031 Provides Paperless Electronic Signature Solution for Businesses
    5. H. D. Smith Establishes Specialty Solutions Organization And Realigns Senior Leadership To Support Growing Geographic Reach, Diversified Businesses
    6. Mesenchymal Stem Cell Research Activity Rose 116% in 2011; Businesses Turning to BioInformant Worldwide for MSC Market Research
    7. Narcolepsy Patient Community Prepares to Share Life Impacts, Treatment Perspectives with FDA Regulators
    8. Abbott Features Solutions to Help Labs Prepare for the Evolving Healthcare Landscape at the American Association for Clinical Chemistry Lab Expo
    9. Frost & Sullivan: Physicians Focus on RCM Solutions to Prepare for New Wave of Financial Challenges
    10. Mylan Specialty L.P. Joins Forces with Adrian Peterson and Jo Frost to Launch Anaphylaxis Preparedness Campaign
    11. Pharmacy Technicians Can Be Leaders In Pharmacy Crime Preparedness
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:6/24/2016)... , June 24, 2016 Dehaier Medical Systems ... "Company"), which develops, markets and sells medical devices and ... , signed a strategic cooperation agreement with Hongyuan Supply ... Supply Chain") on June 20, 2016, to develop Dehaier,s ... strategic cooperation agreement, Dehaier will leverage Hongyuan Supply Chain,s ...
    (Date:6/24/2016)... Mass. , June 24, 2016   Pulmatrix, ... pharmaceutical company developing innovative inhaled drugs, announced today that ... Russell Investments reconstituted its comprehensive set of ... "This is an important milestone for Pulmatrix," ... will increase shareholder awareness of our progress in developing ...
    (Date:6/23/2016)... Research and Markets has announced the addition of the ... report to their offering. ... failure, it replaces the function of kidneys by removing the ... the treatment helps to keep the patient body,s electrolytes such ... Increasing number of ESRD patients & substantial healthcare expenditure on ...
    Breaking Medicine Technology:
    (Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, can now ... and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings ... The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the ...
    (Date:6/25/2016)... Oklahoma (PRWEB) , ... June 25, 2016 , ... ... both athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures ... Oklahoma City area —Johnson is one of the first doctors to perform the ...
    (Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle ... chronic pain and the benefits of holistic treatments, Serenity Recovery Center of ... Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the red ...
    (Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, ... and the Road To Recovery® program to drive cancer patients to and from their ... to ensure the highest quality of life and ongoing independence. Getting to and ...
    (Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... client, The Grove Investment Group (TGIG), has initiated cultivation and processing operations at ... Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of a complete ...
    Breaking Medicine News(10 mins):